KKR builds healthcare portfolio, acquires Healthium MedTechIllustrative image – not actual.

Global investment firm KKR has acquired Bengaluru-based medical devices firm Healthium Medtech from an affiliate of funds advised by private equity firm Apax Partners. The value of the acquisition is Rs 6,500-7,000 crore (around USD 839 million). 

The investment will be made through KKR’s Asian Fund IV, which will acquire a controlling interest in Healthium Group, including Healthium. The transaction is expected to close in the third quarter of calendar year 2024. Healthium is the latest entrant in KKR’s healthcare portfolio in India, which includes formulations company JB, hospital chain Max Healthcare, and generic pharma products company Gland Pharma.

Healthium is a leading home-grown producer of medical devices, known for delivering quality products and a distribution network, both in India and globally. Healthium MedTec, surgical suture manufacturer, looks to further strengthen and expand its market position. It is present in more than 90 countries. KKR will accelerate Healthium’s organic growth and through mergers and acquisitions.

← All latest storiesBack to top →